1. Home
  2. ATHA vs NWGL Comparison

ATHA vs NWGL Comparison

Compare ATHA & NWGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATHA
  • NWGL
  • Stock Information
  • Founded
  • ATHA 2011
  • NWGL 2008
  • Country
  • ATHA United States
  • NWGL Macau
  • Employees
  • ATHA N/A
  • NWGL N/A
  • Industry
  • ATHA Medicinal Chemicals and Botanical Products
  • NWGL
  • Sector
  • ATHA Health Care
  • NWGL
  • Exchange
  • ATHA Nasdaq
  • NWGL Nasdaq
  • Market Cap
  • ATHA 21.0M
  • NWGL 21.2M
  • IPO Year
  • ATHA 2020
  • NWGL 2023
  • Fundamental
  • Price
  • ATHA $0.27
  • NWGL $1.33
  • Analyst Decision
  • ATHA Buy
  • NWGL
  • Analyst Count
  • ATHA 4
  • NWGL 0
  • Target Price
  • ATHA $11.25
  • NWGL N/A
  • AVG Volume (30 Days)
  • ATHA 209.7K
  • NWGL 134.2K
  • Earning Date
  • ATHA 05-14-2025
  • NWGL 05-21-2025
  • Dividend Yield
  • ATHA N/A
  • NWGL N/A
  • EPS Growth
  • ATHA N/A
  • NWGL N/A
  • EPS
  • ATHA N/A
  • NWGL N/A
  • Revenue
  • ATHA N/A
  • NWGL $21,707,613.00
  • Revenue This Year
  • ATHA N/A
  • NWGL N/A
  • Revenue Next Year
  • ATHA N/A
  • NWGL N/A
  • P/E Ratio
  • ATHA N/A
  • NWGL N/A
  • Revenue Growth
  • ATHA N/A
  • NWGL N/A
  • 52 Week Low
  • ATHA $0.25
  • NWGL $1.04
  • 52 Week High
  • ATHA $3.67
  • NWGL $17.21
  • Technical
  • Relative Strength Index (RSI)
  • ATHA 29.05
  • NWGL 40.83
  • Support Level
  • ATHA $0.25
  • NWGL $1.15
  • Resistance Level
  • ATHA $0.31
  • NWGL $1.45
  • Average True Range (ATR)
  • ATHA 0.03
  • NWGL 0.14
  • MACD
  • ATHA -0.00
  • NWGL -0.02
  • Stochastic Oscillator
  • ATHA 12.38
  • NWGL 22.24

About ATHA Athira Pharma Inc.

Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.

About NWGL Nature Wood Group Limited

Nature Wood Group Ltd is a vertically-integrated forestry company that focuses on FSC business operations. It produces various products, including logs, decking, flooring, sawn timber, recycled charcoal, synthesized charcoal, machine-made charcoal, and essential oils. The Group owns natural forest concessions and cutting rights for exploiting timbers on parcels of land in Peru. The Group is organized into two operating divisions; Direct Purchase and Original Design Manufacturer (ODM) Services, and Manufacturing segments. The Direct Purchase and ODM Segment that derives the majority of revenue engages in the business of sourcing live wood and owning designed designs on wood products for sales to end customers. Geographically, the company generates a majority of its revenue from China.

Share on Social Networks: